What is ScriptWorks?
ScriptWorks Compounding Pharmacy specializes in the creation of high-quality, custom compounded medications tailored for both human and animal patients. Operating out of California, the pharmacy collaborates with healthcare providers and veterinarians to develop bespoke pharmaceutical solutions addressing diverse medical requirements. Its PCAB accreditation signifies a commitment to stringent compounding standards. The company serves a broad demographic, encompassing adults, children, and pets, with a primary service area covering the East Bay region and extending across California.
How much funding has ScriptWorks raised?
ScriptWorks has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for ScriptWorks?
The recent strategic investment in ScriptWorks signals a pivotal moment for the company, likely enabling expansion of its compounding capabilities, enhancement of its technological infrastructure, and potentially broadening its geographic reach. As a late-stage entity, this capital infusion is expected to fortify its market leadership in custom pharmaceutical solutions, allowing for further innovation in medication formulation and increased capacity to meet specialized patient needs. The focus on strategic partnerships and adherence to high-quality standards positions ScriptWorks for sustained growth and continued service excellence in the competitive healthcare landscape.
See full ScriptWorks company page
